Products › Human Pharma › Antibiotic
CTSAFE 562.5 mg INJECTION
सीटीसेफ 562.5 मि.ग्रा. इंजेक्शन
CTSAFE 562.5 mg Injection combines ceftriaxone, a third-generation cephalosporin antibiotic, with tazobactam, a beta-lactamase inhibitor. The promotional material presents it for serious susceptible bacterial infections, including respiratory, ear, skin, urinary, bone and joint, intra-abdominal infections, meningitis, and surgical prophylaxis. It is supplied as a vial with carton packaging and must be administered only by a qualified healthcare professional. Use only under the direction of a registered medical practitioner.
Composition
| Ingredient | Strength |
|---|---|
| Ceftriaxone | 500 mg |
| Tazobactam | 62.5 mg |
Benefits
- Provides combined antibacterial and beta-lactamase inhibitor activity
- Supports treatment of susceptible serious bacterial infections
- Designed for professional parenteral administration
- Presented as having rapid distribution and a good safety profile
Indications
- Lower respiratory tract infections
- Acute bacterial otitis media
- Skin and skin structure infections
- Urinary tract infections
- Bone and joint infections
- Intra-abdominal infections
- Meningitis
- Surgical prophylaxis
Target species
Adults, Hospital Use
Pack sizes
562.5 mg vial
Ordering
CTSAFE 562.5 mg INJECTION is supplied in bulk PAN-India by Indo-Safe Healthcare LLP to distributors, veterinary clinics, pharmacies and farms. Request a quotation or contact us at +91 90247 77921.